A40 CYSTIC FIBROSIS AND NON-CYSTIC FIBROSIS BRONCHIECTASIS: Characteristics Of The T-326 Inhaler Important For Effective Inhalation Treatment With Ciprofloxacin Dry Powder For Inhalation In Patients With Non-Cystic Fibrosis Bronchiectasis

In order to ensure reliable and reproducible drug delivery to the lung, all patients (including those with reduced lung function) need to have an inspiratory flow profile that enables effective drug delivery. Conclusions: The aerodynamic characteristics of the T-326 inhaler exhibit an operational PiF window and low inspiratory resistance suitable for patients with NCFB, including those with severe lung function impairment.